← Leaderboards
Hsing-Yu Chen
Harvard Medical School
$129,656
Attributed
$129,656
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $58K · FY2015–17$100K$75K$50K$25K$0
'15
'16
'17
Funding mix
By agency
NIH$129,656 · 1
By mechanism
F32$129,656 · 1
Top collaborators
No co-investigators on record.
Most similar at Harvard Medical School
Same institution · by research overlap
- Christopher D Harvey$16,021,390
- Carlos Federico Lopez$1,806,568
- Kevin Esvelt$4,518,721
- Jennifer Ding$221,404
- Karthik Hullahalli$110,751
Others in their field
Top investigators on “Affect”
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$287,585,588
- Chanza Baytop · Westat, Inc.$271,217,917
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$209,385,844
- David Heimbrook · Leidos Biomedical Research, Inc.$168,138,264
- Daniel R Kuritzkes · Brigham And Women'S Hospital$151,687,019
Research focus
AffectAnimal ModelAnimalsAnticancer ResearchAscitesBaseBiological MarkersBiological ModelsBrca1 GeneCancer CellCancer PatientCancer TherapyCarboplatinCareerCell Culture TechniquesCellsChemotherapyChromosomal InstabilityClinicClinically RelevantClinical OncologyCollaborationsCollectionCombinatorial
Grant awards (3)
Elucidation of the impact of commonly co-altered genes on chemosensitivity using a novel model of high-grade serous ovarian cancer$17,460
F32 · FY2017 · CA · contact PI
Elucidation of the impact of commonly co-altered genes on chemosensitivity using a novel model of high-grade serous ovarian cancer$58,002
F32 · FY2016 · CA · contact PI
Elucidation of the impact of commonly co-altered genes on chemosensitivity using a novel model of high-grade serous ovarian cancer$54,194
F32 · FY2015 · CA · contact PI